NCT01542463View on ClinicalTrials.gov

Evaluation of the Use of Levemir® in Insufficiently Controlled Patients With Type 1 or Type 2 Diabetes

CompletedOBSERVATIONAL

Enrollment

4,464

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

July 31, 2007

Study Completion Date

July 31, 2007

Conditions

DiabetesDiabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Interventions

DRUG

insulin detemir

Prescribed at the discretion of the physician

Trial Locations (1)

55127

Mainz

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY